FINWIRES · TerminalLIVE
FINWIRES

AtkinsRealis Group Price Target Lowered to $117 at TD

By

TD Securities lowered its price target on AtkinsRealis Group Inc. (ATRL.TO) to $117 from $127 on Friday.

Analyst Michael Tupholme maintained a Buy rating on shares of the Canadian engineering services and nuclear company following its Q1 results.

"We see an H2/26 nuclear tech. decision in Ontario as a re-rating catalyst," Tupholme said in a note to clients.

"Also, we believe the 2026 Nuclear revenue guide could be conservative, given Q1/26 growth of +37% y/y vs. vs. FY2026 guide of +9% y/y," the analyst said. "ESR org. growth is strong and FY2026 ESR margin expansion remains intact."

Tupholme said the price target reduction is due to a "reduced ESR target multiple of 11.0x (was 12.5x), reflecting lower sector valuations."

Related Articles

Research

Wedbush Initiates Solventum at Outperform With $94 Price Target

Solventum (SOLV) has an average rating of overweight and mean price target of $83, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$SOLV
Research

Chardan Raises Price Target on Senti Biosciences to $12 From $11, Keeps Buy Rating

$SNTI
Research

Calian Group Price Targets Raised at RBC, Desjardins

Analysts at RBC Capital Markets and Desjardins raised their price targets on Calian Group Ltd. (CGY.TO) to $90 from $78, and to $90 from $83, respectively.RBC analyst Paul Treiber maintained an Outperform rating on shares of the Canadian diverse products and services company following its quarterly results.The stock rose $14.24, or 20.9%, to $82.24 on the Toronto Stock Exchange."Calian reported a solid quarter, with revenue, adj. EBITDA, and adj. EPS all above RBC/consensus," Treiber said in a note to clients."Organic growth strengthened and bookings were strong, primarily due to increasing demand from defence customers, along with a recovery in US commercial," the analyst said.We believe acquisitions in the defence segment are potential catalysts for the stock," Treiber said.Desjardins analyst Benoit Poirier maintained a Buy rating on Calian."This quarter marked an important inflection in CGY's defence business after months of newsflow and questions we are now actually starting to see tangible execution/bookings from increased budgets/ spending in both Canada and Europe," Poirier said in a note to clients."...With the stock now trading at a premium to its five-year average, potential acquisitions will become even more accretive," the analyst said.

$CGY.TO